INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $61,000 | -63.0% | 1,097 | -51.7% | 0.00% | -66.7% |
| Q1 2022 | $165,000 | +42.2% | 2,270 | +162.1% | 0.01% | +50.0% |
| Q3 2021 | $116,000 | +33.3% | 866 | -80.2% | 0.00% | -55.6% |
| Q3 2020 | $87,000 | +1640.0% | 4,371 | +1518.9% | 0.01% | +350.0% |
| Q1 2019 | $5,000 | +400.0% | 270 | +250.6% | 0.00% | – |
| Q4 2018 | $1,000 | -98.3% | 77 | -96.3% | 0.00% | -100.0% |
| Q3 2018 | $60,000 | +757.1% | 2,083 | +739.9% | 0.02% | +950.0% |
| Q2 2018 | $7,000 | -89.2% | 248 | -91.9% | 0.00% | -94.1% |
| Q1 2018 | $65,000 | – | 3,065 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |